Guiñazú, G., Dvorkin, J., Mahmud, S., Baral, R., Pecenka, C., Libster, R., . . . Caballero, M. T. (2025). Corrigendum to “Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina” [Vaccine. Volume 42, Issue 23, 3 October 2024, 126234]. Vaccine, 44, 126402. https://doi.org/10.1016/j.vaccine.2024.126402
Chicago Style (17th ed.) CitationGuiñazú, Gonzalo, Julia Dvorkin, Sarwat Mahmud, Ranju Baral, Clint Pecenka, Romina Libster, Andrew Clark, and Mauricio T. Caballero. "Corrigendum to “Evaluation of the Potential Impact and Cost-effectiveness of Respiratory Syncytial Virus (RSV) Prevention Strategies for Infants in Argentina” [Vaccine. Volume 42, Issue 23, 3 October 2024, 126234]." Vaccine 44 (2025): 126402. https://doi.org/10.1016/j.vaccine.2024.126402.
MLA (9th ed.) CitationGuiñazú, Gonzalo, et al. "Corrigendum to “Evaluation of the Potential Impact and Cost-effectiveness of Respiratory Syncytial Virus (RSV) Prevention Strategies for Infants in Argentina” [Vaccine. Volume 42, Issue 23, 3 October 2024, 126234]." Vaccine, vol. 44, 2025, p. 126402, https://doi.org/10.1016/j.vaccine.2024.126402.